Latest filings (excl ownership)
S-1/A
IPO registration (amended)
15 Mar 24
10-K
2023 FY
Annual report
15 Mar 24
S-1
IPO registration
12 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Dec 23
EFFECT
Notice of effectiveness
18 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
15 Dec 23
CORRESP
Correspondence with SEC
14 Dec 23
S-3/A
Shelf registration (amended)
8 Dec 23
CORRESP
Correspondence with SEC
6 Dec 23
CORRESP
Correspondence with SEC
30 Nov 23
8-K
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
17 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
20 Oct 23
DEFA14A
Additional proxy soliciting materials
17 Oct 23
DEFA14A
Additional proxy soliciting materials
17 Oct 23
DEFA14A
Additional proxy soliciting materials
16 Oct 23
DEFA14A
Additional proxy soliciting materials
13 Oct 23
DEFA14A
Additional proxy soliciting materials
11 Oct 23
DEFA14A
Additional proxy soliciting materials
11 Oct 23
DEFA14A
Additional proxy soliciting materials
22 Sep 23
8-K
Submission of Matters to a Vote of Security Holders
22 Sep 23
DEFA14A
Additional proxy soliciting materials
15 Sep 23
8-K
Changes in Registrant's Certifying Accountant
15 Sep 23
UPLOAD
Letter from SEC
12 Sep 23
S-3
Shelf registration
30 Aug 23
10-Q
2023 Q2
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
ARS
2022 FY
Annual report to shareholders
7 Aug 23
DEFA14A
Additional proxy soliciting materials
7 Aug 23
DEF 14A
Definitive proxy
7 Aug 23
8-K
Departure of Directors or Certain Officers
7 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
23 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Soligenix Announces Pricing of $8.5 Million Public Offering
9 May 23
EFFECT
Notice of effectiveness
8 May 23
424B4
Prospectus supplement with pricing info
5 May 23
S-1/A
IPO registration (amended)
4 May 23
CORRESP
Correspondence with SEC
4 May 23
8-K
Strengthens regulatory and orphan drug development expertise
3 May 23
Latest ownership filings
4
JEROME B ZELDIS
15 Dec 23
4
Diane L. Parks
15 Dec 23
4
ROBERT J. RUBIN
15 Dec 23
4
ANTHONY GREGG LAPOINTE
15 Dec 23
4
Oreola Donini
8 Dec 23
4
Richard Straube
8 Dec 23
4
CHRISTOPHER J SCHABER
8 Dec 23
4
Jonathan L. Guarino
8 Dec 23
4
Timothy R. Cote
5 May 23
3
Timothy R. Cote
5 May 23
4
Richard Straube
9 Dec 22
4
Oreola Donini
9 Dec 22
4
Jonathan L. Guarino
9 Dec 22
4
CHRISTOPHER J SCHABER
9 Dec 22
4
JEROME B ZELDIS
21 Nov 22
4
ROBERT J. RUBIN
21 Nov 22
4
Diane L. Parks
21 Nov 22
4
ANTHONY GREGG LAPOINTE
21 Nov 22
4
Richard Straube
18 May 22
4
CHRISTOPHER J SCHABER
18 May 22
4
Jonathan L. Guarino
21 Jan 22
4
CHRISTOPHER J SCHABER
21 Jan 22
4
CHRISTOPHER J SCHABER
4 Jan 22
4
CHRISTOPHER J SCHABER
20 Dec 21
4
Jonathan L. Guarino
15 Dec 21
4
Jonathan L. Guarino
15 Dec 21
4
CHRISTOPHER J SCHABER
14 Dec 21
4
CHRISTOPHER J SCHABER
10 Dec 21
4
Oreola Donini
10 Dec 21
4
Jonathan L. Guarino
10 Dec 21
4
Richard Straube
10 Dec 21
4
ROBERT J. RUBIN
24 Sep 21
4
ANTHONY GREGG LAPOINTE
24 Sep 21
4
JEROME B ZELDIS
24 Sep 21
4
Diane L. Parks
24 Sep 21
4
JEROME B ZELDIS
18 May 21
4
CHRISTOPHER J SCHABER
4 Jan 21
4
Jonathan L. Guarino
11 Dec 20
4
Richard Straube
11 Dec 20
4
CHRISTOPHER J SCHABER
11 Dec 20